Literature DB >> 11248646

Bilateral testicular lymphoma treated with chemotherapy and radiation without orchiectomy: complete response relapsed at 52 months in the vitreous humor.

J W Davis1, R P Moriarty, S M Schlossberg, P F Schellhammer.   

Abstract

We report the first detailed case of testicular lymphoma managed with chemotherapy and radiation without orchiectomy. A 60-year-old man with Stage II extralymphatic bilateral testicular lymphoma refused orchiectomy, but underwent cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and radiation. He remained disease free for 52 months, when a solitary central nervous system relapse to the vitreous humor was diagnosed. The optimal therapy for testicular lymphoma is unclear but often includes orchiectomy with adjuvant chemotherapy and radiation. Stage I testicular lymphoma can be cured by surgery alone; however, the relapse rates for all stages of testicular lymphoma are high despite systemic therapy. For Stage II disease and higher, chemotherapy/radiation is recommended; orchiectomy may not be mandatory.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11248646     DOI: 10.1016/s0090-4295(00)01022-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Primary testicular and intraocular lymphomas: two case reports and a review of the literature.

Authors:  Dana J Wallace; Chandra R Altemare; De Fen Shen; Marc D deSmet; Ronald R Buggage; Robert B Nussenblatt; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 6.048

2.  Molecular pathology of primary intraocular lymphoma.

Authors:  Chi-Chao Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2003

Review 3.  Primary testicular lymphoma: experience with 13 cases and literature review.

Authors:  Chu Wang; Hai Wang; Qinghai Wang; Bingbing Shi
Journal:  Int J Hematol       Date:  2013-01-25       Impact factor: 2.490

4.  Vitreoretinal lymphoma following primary testicular lymphoma: Report of two cases and review of the literature.

Authors:  Joseph B Alsberge; Robert N Johnson
Journal:  Am J Ophthalmol Case Rep       Date:  2021-10-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.